Home Help Search Archive Feedback

Rapid Responses to:

M G Myriam Hunink
Does evidence based medicine do more good than harm?
BMJ 2004; 329: 1051 [Full text]
*Rapid Responses: Submit a response to this article

Rapid Responses published:

[Read Rapid Response] Evidence-Based Investigation into the Relation Between Sexual Intercourse and Pregnancy
Jacob M. Puliyel, Noopur Baijal, Dherain Narula.   (10 November 2004)

Evidence-Based Investigation into the Relation Between Sexual Intercourse and Pregnancy 10 November 2004
Jacob M. Puliyel,
Consultant Pediatrician
West Middlesex University Hospital Middlesex TW7 6AF,
Noopur Baijal, Dherain Narula.

Send response to journal:
Re: Evidence-Based Investigation into the Relation Between Sexual Intercourse and Pregnancy

Critical appraisal at the expense of critical thinking.

A 15 year old girl from an all-girls boarding-school was found to be pregnant. She denied a history of sexual intercourse. We did this study to see if there is any relationship between pregnancy and sexual intercourse.

Structured clinical question:

In girls (patient) is sexual intercourse (intervention) and pregnancy (outcome) related?

Search strategy and outcome:

Medline 1966-February 2004 using PubMed : �sexual intercourse� AND �pregnancy�. Limits: Unlimited and All languages

No relevant or irrelevant paper were found

Apparent Clinical Bottom Line:

No evidence was found to support the popular belief that pregnancy results from sexual intercourse.


Our search strategy was similar to that used by Parikh and Maconochie (1) who found no evidence to support the �glass test� in the diagnosis of petechiae . We found there was no evidence to substantiate the belief that sexual intercourse is a prelude to pregnancy.

Reductio ad absurdum is a mode of argument that seeks to establish a contention by deriving an absurdity from its denial, thus arguing that the thesis must be accepted because its rejection would be untenable. We contend that the EBM technique used for testing the glass test is fallacious

There is a small chance that a good double blind randomized placebo controlled study was indeed done, looking at sexual intercourse and pregnancy but it did not get past the peer review process and so we could not retrieve it in our search of literature after 1966.

It is possible that the EBM penchant for excessive structure and oversimplification (take for example the �structured clinical question�: In a child with a rash (patient) does a positive glass tumbler test (test) really pick up petechiae (outcome); It is worded as if feeble-minded readers would confuse the patient and the test, unless identified in parentheses) leads to use of �search terms� that are inappropriate. To test if changing the search terms can makes a difference to the yield in this form of arm-chair-research, we decided to look for the term �non- blanching rash� AND �purpura� in a search limited to the archives of the Archives of Disease in Childhood after 2000, and it yielded the paper by Wells et al (2) where the authors specifically studied �non-blanching rash (defined by them as a rash that does not blanch when pressed with a glass) and meningococcemia.


There is little evidence that EBM improves patient-satisfaction with treatment but there is emerging evidence that it can do harm. The New England Journal of Medicine reports about Merck�s drug Rofecoxib that was withdrawn (after more than 80 million patients had taken this medicine and annual sales had topped $2.5 billion,) because of the risk of myocardial infarctions and strokes(4). Initially, peer-reviewed-literature was flooded by papers from the employees of Merck and their consultants. Meta- analysis does not discount papers, with a declared conflict-of-interest. It removed the label of bias and facilitated this fudge. Many epidemiological studies showed concerns about myocardial infarction with Rofecoxib, but Merck (like a good evidence-based-practitioner), claimed that only randomized-controlled-trials were suitable for determining whether there was any risk! The editorial concludes, �Given the finding.... of an excess of 16 myocardial infarctions or strokes per 1000 patients receiving the drug (and that 80 million received the drug,) there may be tens of thousands of patients who have had major adverse events attributable to Rofecoxib�. We submit that, had it not been for EBM�s farcical �hierarchy of evidence� (4) cognizance of the epidemiological evidence would have been taken, and the harm could have been avoided. Indeed we see here, that EBM can perhaps do more harm than good.

It is unfortunate that medical science has allowed one system of literature-search, to abrogate to itself the eponym �Evidence Based Medicine� to the exclusion of other sensible methods of finding the relative harms and benefits of medical interventions. It is our contention that this exclusive usage of the term EBM is pejorative of all other methods and is therefore the stumbling block to evaluating the real evidence. Critical thinking, rather than mindless critical appraisals, is what is needed. Like Professor Bastion, we too are diehard-evidence- enthusiasts (5) but we are not enamoured by EBM.


1. Parikh A, Maconochie I. What is the use of the glass test? Arch. Dis. Child. 2003; 88: 1135.

2. Wells LC, Smith JC, Weston VC, Collier J, and Rutter N The child with a non-blanching rash: how likely is meningococcal disease? Arch. Dis. Child. 2001; 85: 218 - 222.

3. Topol EJ. Failing the public health -- Rofecoxib, Merck, and the FDA. N Engl J Med 2004; 351:1707-9.

4. Hunink MGM Does evidence based medicine do more good than harm BMJ 2004;329:1051

5. Bastian H Learning from evidence based mistakes BMJ 2004;329:1053

Competing interests: None declared

Home Help Search Archive Feedback
BMJ BMJ Career Focus email alerts
© 2006 BMJ Publishing Group Ltd